BROKERS CHOICE: APOLLOHOSPI, KIMS, ASTERDM, DIVISLAB, ZOMATO, LIFEINSURANCE, VEDANTA, PBFINTECK, RELIANCE

AHMEDABAD, 29 NOVEMBER: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

HSBC on Apollo Hospitals: Maintain Buy on Company, target price at Rs 8220/Sh (Positive)

HSBC on KIMS: Maintain Buy on Company, target price at Rs 670/Sh (Positive)

HSBC on Rainbow: Maintain Buy on Company, target price at Rs 1800/Sh (Positive)

HSBC on Aster DM: Maintain Buy on Company, target price at Rs 550/Sh (Positive)

Citi on Divis Lab: Maintain Buy on Company, target price at Rs 6850/Sh (Positive)

ICICI on Allied Blenders: Initiate Buy on Company, target price at Rs 400/Sh (Positive)

Citi on Kalyan Jewel: Maintain Buy on Company, target price at Rs 810/Sh (Positive)

Morgan Stanley on Life Insurance: If caps are implemented, this would likely be negative for APE growth (Neutral)

Bernstein on Life Insurance: India Life Insurance: Regulatory scrutiny on bank sales intensifying (Neutral)

Kotak Securities on Life Insurance: Believe diversification of distribution is anyway a secular and inevitable trend (Neutral)

Jefferies on Zomato: Maintain Buy on Company, target price at Rs 335/Sh (Neutral)

Bernstein on Jubilant Food: Maintain Outperform on Company, target price at Rs 700/Sh (Neutral)

BofA on PB Fintech: Maintain Neutral on Company, target price at Rs 1850/Sh (Neutral)

Investec on Vedanta: Maintain Hold on Company, target price at Rs 510/Sh (Neutral)

MS on Reliance Ind: Maintain Overweight on Company, target price at Rs 1662/Sh (Neutral)

Goldman Sachs on Financials: Sizing microfinance stress: US$4bn – US$18 bn of potential stressed pool Diversified players better placed (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)